ZA947948B - Indole derivatives - Google Patents

Indole derivatives

Info

Publication number
ZA947948B
ZA947948B ZA947948A ZA947948A ZA947948B ZA 947948 B ZA947948 B ZA 947948B ZA 947948 A ZA947948 A ZA 947948A ZA 947948 A ZA947948 A ZA 947948A ZA 947948 B ZA947948 B ZA 947948B
Authority
ZA
South Africa
Prior art keywords
indole derivatives
indole
derivatives
Prior art date
Application number
ZA947948A
Other languages
English (en)
Inventor
Alfredo Cugola
Romano Di Fabio
Giorgio Pentassuglia
Original Assignee
Glaxo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Spa filed Critical Glaxo Spa
Publication of ZA947948B publication Critical patent/ZA947948B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA947948A 1993-10-14 1994-10-12 Indole derivatives ZA947948B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939321221A GB9321221D0 (en) 1993-10-14 1993-10-14 Heterocyclic compounds

Publications (1)

Publication Number Publication Date
ZA947948B true ZA947948B (en) 1995-05-23

Family

ID=10743550

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA947948A ZA947948B (en) 1993-10-14 1994-10-12 Indole derivatives

Country Status (27)

Country Link
US (3) US5760059A (enExample)
EP (1) EP0723541A1 (enExample)
JP (1) JPH09503770A (enExample)
CN (1) CN1070490C (enExample)
AP (1) AP574A (enExample)
AU (1) AU681194B2 (enExample)
BG (1) BG61839B1 (enExample)
CA (1) CA2171449A1 (enExample)
CO (1) CO4290355A1 (enExample)
CZ (1) CZ92396A3 (enExample)
FI (1) FI961628A0 (enExample)
GB (1) GB9321221D0 (enExample)
HU (1) HU219710B (enExample)
IL (1) IL111294A (enExample)
IS (1) IS4219A (enExample)
MY (1) MY112411A (enExample)
NO (1) NO309861B1 (enExample)
NZ (1) NZ274179A (enExample)
OA (1) OA10578A (enExample)
PE (1) PE21995A1 (enExample)
PL (1) PL179568B1 (enExample)
RU (1) RU2144535C1 (enExample)
SG (1) SG49013A1 (enExample)
SK (1) SK44996A3 (enExample)
TW (1) TW283144B (enExample)
WO (1) WO1995010517A1 (enExample)
ZA (1) ZA947948B (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9321221D0 (en) * 1993-10-14 1993-12-01 Glaxo Spa Heterocyclic compounds
GB9704499D0 (en) * 1997-03-05 1997-04-23 Glaxo Wellcome Spa Method of manufacture
GB9704498D0 (en) * 1997-03-05 1997-04-23 Glaxo Wellcome Spa Chemical compound
WO2000056711A1 (en) * 1999-03-23 2000-09-28 Sumitomo Pharmaceuticals Co., Ltd. Tricyclic indole-2-carboxylic acid compound used as nmda receptor antagonist
RU2209041C2 (ru) * 2000-06-15 2003-07-27 Новосибирский научно-исследовательский институт травматологии и ортопедии Способ лечения церебрального вазоспазма
DE10153346A1 (de) 2001-10-29 2004-04-22 Grünenthal GmbH Substituierte Indole
WO2003039540A2 (en) * 2001-11-09 2003-05-15 Sepracor Inc. D-amino acid oxidase inhibitors for learning and memory
KR20060128976A (ko) 2003-12-29 2006-12-14 세프라코 아이엔시. 피롤 및 피라졸 디에이에이오 억제제
CA2957667A1 (en) 2005-07-06 2007-01-11 Sepracor Inc. Combinations of eszopiclone and trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-n-methyl-1-napthalenamine or trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders
RU2425830C2 (ru) * 2005-12-01 2011-08-10 Ф. Хоффманн-Ля Рош Аг Новые производные винилогенных кислот
WO2007081857A2 (en) * 2006-01-06 2007-07-19 Sepracor Inc. Cycloalkylamines as monoamine reuptake inhibitors
KR101381768B1 (ko) * 2006-01-06 2014-04-07 선오비온 파마슈티컬스 인코포레이티드 테트랄론-기재 모노아민 재흡수 저해제
AU2007233041B2 (en) 2006-03-31 2013-05-02 Sepracor Inc. Preparation of chiral amides and amines
US7884124B2 (en) * 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
US7579370B2 (en) * 2006-06-30 2009-08-25 Sepracor Inc. Fused heterocycles
US20080082066A1 (en) * 2006-10-02 2008-04-03 Weyerhaeuser Co. Crosslinked carboxyalkyl cellulose fibers having non-permanent and temporary crosslinks
EP2074092A2 (en) 2007-01-18 2009-07-01 Sepracor Inc. Inhibitors of d-amino acid oxidase
US7902252B2 (en) * 2007-01-18 2011-03-08 Sepracor, Inc. Inhibitors of D-amino acid oxidase
CA2688493C (en) 2007-05-31 2016-04-19 Sepracor Inc. Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors
US20100120740A1 (en) * 2008-08-07 2010-05-13 Sepracor Inc. Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
KR20110126132A (ko) * 2009-03-10 2011-11-22 산텐 세이야꾸 가부시키가이샤 4,6-디클로로-1η-인돌-2-카르복실산 유도체 또는 이의 염을 유효 성분으로서 함유하는 시신경 장애의 예방 또는 치료제
US20110034434A1 (en) * 2009-08-07 2011-02-10 Sepracor Inc. Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
AU2012321345B2 (en) 2011-10-03 2016-03-17 The University Of Utah Research Foundation Application of 5-HT6 receptor antagonists for the alleviation of cognitive deficits of down syndrome
DK3137658T3 (da) 2014-04-30 2022-05-02 Yufeng Jane Tseng Anvendelse af kendte forbindelser som d-aminosyreoxidase-inhibitorer
KR20240042153A (ko) 2016-09-14 2024-04-01 위펑 제인 쳉 D-아미노산 옥시다제 (daao) 저해제로서 신규한 치환된 벤즈이미다졸 유도체

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256673A (en) * 1983-11-25 1993-10-26 Merck Patent Gesellschaft Mit Beschrankter Haftung Indole-3-yl-A-tetrahydropyridyl or piperidyl compounds
US4960786A (en) * 1989-04-24 1990-10-02 Merrell Dow Pharmaceuticals Inc. Excitatory amino acid antagonists
PT93943A (pt) * 1989-05-05 1991-02-08 Searle & Co Processo para a preparacao de composicoes contendo compostos indole-2-carboxilato para tratamento de perturbacoes do snc
DE4101686A1 (de) * 1991-01-22 1992-07-23 Merck Patent Gmbh Indolderivate
US5284862A (en) * 1991-03-18 1994-02-08 Warner-Lambert Company Derivatives of 2-carboxyindoles having pharmaceutical activity
US5145845A (en) * 1991-05-14 1992-09-08 Warner-Lambert Co. Substituted 2-carboxylindoles having pharmaceutical activity
CA2083891A1 (en) * 1991-12-03 1993-06-04 Angus Murray Macleod Heterocyclic compounds, compositions containing them and their use in therapy
GB9208492D0 (en) * 1992-04-16 1992-06-03 Glaxo Spa Heterocyclic compounds
ZA936492B (en) * 1992-09-10 1995-03-02 Lilly Co Eli Compounds useful as hypoglycemic agents and for treating Alzheimer's disease.
DE4333254A1 (de) * 1993-09-30 1995-04-06 Merck Patent Gmbh Piperidine und Piperazine
GB9321221D0 (en) * 1993-10-14 1993-12-01 Glaxo Spa Heterocyclic compounds

Also Published As

Publication number Publication date
IL111294A0 (en) 1994-12-29
IL111294A (en) 1998-12-06
CO4290355A1 (es) 1996-04-17
GB9321221D0 (en) 1993-12-01
FI961628A7 (fi) 1996-04-12
CZ92396A3 (en) 1996-08-14
PL313969A1 (en) 1996-08-05
CN1133042A (zh) 1996-10-09
AU7813394A (en) 1995-05-04
PL179568B1 (pl) 2000-09-29
AU681194B2 (en) 1997-08-21
TW283144B (enExample) 1996-08-11
JPH09503770A (ja) 1997-04-15
EP0723541A1 (en) 1996-07-31
HU219710B (hu) 2001-06-28
SG49013A1 (en) 1998-05-18
IS4219A (is) 1995-04-15
AP574A (en) 1997-01-30
SK44996A3 (en) 1997-01-08
RU2144535C1 (ru) 2000-01-20
CA2171449A1 (en) 1995-04-20
HUT76065A (en) 1997-06-30
WO1995010517A1 (en) 1995-04-20
US6100289A (en) 2000-08-08
BG100511A (en) 1996-11-29
AP9400685A0 (en) 1994-10-31
NO961475L (no) 1996-04-12
BG61839B1 (bg) 1998-07-31
US5962496A (en) 1999-10-05
NO309861B1 (no) 2001-04-09
NO961475D0 (no) 1996-04-12
PE21995A1 (es) 1995-08-14
CN1070490C (zh) 2001-09-05
NZ274179A (en) 1998-01-26
MY112411A (en) 2001-06-30
FI961628A0 (fi) 1996-04-12
HU9600969D0 (en) 1996-06-28
OA10578A (en) 2002-06-07
US5760059A (en) 1998-06-02

Similar Documents

Publication Publication Date Title
HU9402983D0 (en) Indol derivatives
GB2266091B (en) Indole derivatives
ZA942383B (en) New indole derivatives
ZA941483B (en) Indole derivatives
HU9301003D0 (en) Indole derivatives
SG49013A1 (en) Indole derivatives
ZA947210B (en) Indole derivatives
GB9326332D0 (en) Indole derivatives
EP0512350A3 (en) Indole derivatives
IL109376A0 (en) Indole derivatives
GB9116732D0 (en) Indole derivatives
GB9204024D0 (en) Indole derivatives
GB9310092D0 (en) Indole derivatives
GB9302577D0 (en) Indole derivatives
GB9307080D0 (en) Indole derivatives
GB9309148D0 (en) Indole derivatives
GB9319299D0 (en) Indole derivatives
GB9206809D0 (en) Indole derivatives
GB9218595D0 (en) Indole derivatives
GB9206810D0 (en) Indole derivatives
GB9206056D0 (en) Indole derivatives
GB9206794D0 (en) Indole derivatives
GB9215961D0 (en) Indole derivatives
GB9206787D0 (en) Indole derivatives
IL121326A0 (en) Indole derivatives